Image

Enhanced Rehabilitation After Major Trauma (PROPERLY)

Enhanced Rehabilitation After Major Trauma (PROPERLY)

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this study is to assess the feasibility of recruitment, and barriers to delivery of an enhanced rehabilitation service, in patients surviving major trauma.

The main questions it aims to answer are:

are the investigators able to recruit patients to a research study are the investigators able to retain patients in the research study are the investigators able to identify appropriate primary outcome measures are the investigators able to identify barriers to future large-scale definitive trial or service delivery Participants will would be offered at least two sessions of the Enhanced Rehabilitation Programme (ERP), each lasting 60-120 minutes per week, delivered in the Manchester Institute of Health and Performance (MIHP).

Participants not willing to travel to the MIHP, or declining to engage in the ERP, will be asked to join the Standard Care (SC) group. This group will provide questionnaire data and clinical outcome measure collection with their usual place of therapy.

Researchers will compare the ERP group and the SC groups to assess any additional benefits to the ERP.

Description

The investigators will aim to recruit 25 participants for the ERP and 25 participants in SC (50 in total) who will go through a series of quantitative functional assessments and patient reported outcome measures, at baseline (at the beginning of the programme), middle (3 months), on discharge from the programme (usually 6 months). If patients are discharged earlier, assessments will be performed at the discharge visit.

Assessments using PROMS will be conducted at baseline (at the beginning of the programme), middle (3 months), on discharge from the programme (usually 6 months), and 12 months.

Eligibility

Inclusion Criteria:

  • Participants over 18 years old
  • Registered GP in Greater Manchester or Greater Manchester Resident.
  • Polytrauma or one or more complex /severe isolated injury
  • Rehabilitation goals (e.g., mobility, function, job retention/ return to work) identified using shared decision-making process
  • Patient able to enter programme 6-30 months post injury.
  • For the ERP patients willing to travel to the MIHP for their evaluation and treatment twice a week.
  • Participants with lower limb injuries that continue to have functional impairment.
  • Participants deemed well and safe enough to participate by clinical teams.
  • Normal ECG if previously reported to have abnormal ECG
  • Participants willing to consent to follow up over 12 months
  • Participants with the capacity to consent to the study.
  • Fully healed wounds and bone healed sufficiently to allow at least partial weight bearing

Exclusion Criteria:

  • Participants under the age of 18
  • Participants unable to provide informed consent
  • Participants with multiple pre-existing comorbidities that affect ability to participate in enhanced rehabilitation such as cognitive impairment, unstable angina.
  • Central motor neurological impairment affecting ability to participate in an enhanced rehab programme
  • Absence of functional disability affecting gait and / or function.
  • Plans for further surgery that will impact on gait or function.

Study details
    Major Trauma

NCT05652790

Manchester University NHS Foundation Trust

18 May 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.